A detailed history of Banque De Luxembourg S.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, Banque De Luxembourg S.A. holds 466 shares of LLY stock, worth $476,112. This represents 0.21% of its overall portfolio holdings.

Number of Shares
466
Holding current value
$476,112
% of portfolio
0.21%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 21, 2026

BUY
$799.57 - $1025.28 $372,599 - $477,780
466 New
466 $501 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Banque De Luxembourg S.A. Portfolio

Follow Banque De Luxembourg S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque De Luxembourg S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banque De Luxembourg S.A. with notifications on news.